Ann: 2021 Annual Report to Shareholders, page-54

Turtle, Ironically, I made my first IBX 'Buy' during May 2020 - Well and truly after that timeline that wasn't met in your video...
And, I'm assuming many others here on Hotcopper also invested after May 2020 with the full knowledge that previous timelines
weren't met - Why? because of the Co's potential to unlock value and because I've seen many other examples of timeline
blowouts in this sector.

Nothing wrong with that if done with a clear view of risks as well as potential rewards. I believe there are only three outcomes
here: 1) We complete our first-in-human trial with successful results; 2) We don't complete our first-in-human trials due
to lack of patient recruitment numbers (extremely unlikely, IMO), or 3) Our technology fails. Different probabilities for each
of the three outcomes...

However, I believe there is far more "chance of success" in completing our trial successfully during the first half of 2022
then some (minority only) of the commentary here is suggesting. Not long to wait and hopefully, the Co's beliefs in the tech
will be substantiated!